PB 4 of 2016

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 1)

National Health Act 1953

 

 

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 25 January   2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

JULIANNE QUAINE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

 

 

 

___________________________________________________________________________

 

Amendment determination  Pharmaceutical Benefits Early Supply

 

 

1 Name of Instrument

 

(1)           This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2016 (No. 1)

 

(2)           This Instrument may also be cited as PB 4 of 2016.

 

2 Commencement

 

This Instrument commences on 1 February 2016.

 

3 Amendment of PB 120 of 2016

 

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

 

 

Schedule 1 Amendments

 

[1]       Schedule 1, after entry for Rotigotine in the form Transdermal patch 9 mg

insert:

Ruxolitinib

Tablet 5 mg

20

112

5

 

Ruxolitinib

Tablet 15 mg

20

56

5

 

Ruxolitinib

Tablet 20 mg

20

56

5